Cutaneous melanoma causes 55 500 deaths annually. The incidence and mortality rates of
the disease differ widely across the globe depending on access to early detection and …

Most patients with BRAF V600 -mutant metastatic melanoma develop resistance to selective
RAF kinase inhibitors. The spectrum of clinical genetic resistance mechanisms to RAF …

… Selma Ugurel has received grants and travel support from Medac, personal fees from Roche
and MSD, and travel support from BMS. Ralf Gutzmer has received personal fees from BMS…

The molecular biology of metastatic potential in melanoma has been studied many times
previously and changes in the expression of many genes have been linked to metastatic …

… Selma Ugurel has received grants and travel support from Medac, personal fees from Roche
and MSD, and travel support from BMS. Ioannis Thomas has received travel support from …

PURPOSE: To determine the predictive value of the angiogenic serum factors angiogenin,
vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and …

Background Recent studies have successfully demonstrated the use of deep-learning
algorithms for dermatologist-level classification of suspicious lesions by the use of excessive …

The treatment of metastatic melanoma is still undergoing a process of major change. The
two most important novel therapeutic strategies, selective kinase inhibitors and immune …

Background In recent studies, convolutional neural networks (CNNs) outperformed
dermatologists in distinguishing dermoscopic images of melanoma and nevi. In these studies, …

Background Recent studies have demonstrated the use of convolutional neural networks (CNNs)
to classify images of melanoma with accuracies comparable to those achieved by …